Not a good buy right now: the stock is in a clear downtrend (bearish moving-average stack) and is trading below key support (S1 0.477), which keeps downside risk elevated.
Oversold (RSI_6 ~16.7) can produce bounces, but with no proprietary buy signals and no news catalyst, this looks more like a low-quality “dead-cat bounce” setup than a strong entry.
For an impatient buyer who won’t wait for confirmation, the current setup is not attractive; I would avoid new long entries here.
Momentum: MACD histogram is negative (-0.0175) and still below zero; while it’s “negatively contracting” (selling pressure easing), it has not flipped bullish.
RSI: RSI_6 at ~16.7 is deeply oversold, which can trigger short-term rebounds, but oversold alone is not a reliable buy signal in a strong downtrend.
Levels: Current price ~0.4539 is below S1 (0.477), implying broken support; next key downside level is S2 (0.408). Upside levels to reclaim would be Pivot 0.589 then R1 0.701.
Near-term pattern stats (similar candlesticks): weak/flat expectations (next day slightly negative bias; next week/month ~flat), not signaling a strong edge.
Positive Catalysts
increases the probability of a short-term technical bounce.
is positive (+17.63% YoY).
Neutral/Negative Catalysts
with price trading below key support (S1 0.477).
Trading trends: hedge funds and insiders are reported as neutral (no supportive accumulation signal).
Financial Performance
Latest quarter: 2025/Q3.
Revenue: $1,603,392, up 17.63% YoY (growth is a plus).
Net income: -1,500,789 (still a loss), though improved YoY (as provided).
EPS: -0.10, improved YoY (as provided), but still negative.
Gross margin: 3.06 (low), improved YoY; margin profile remains a constraint for a sustained rerating.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target data was provided, so there’s no clear Wall Street consensus trend to lean on.
With no visible upgrades/targets and no near-term catalysts in the news flow, the “pros vs cons” setup skews negative: technicals are bearish and fundamentals are improving but still loss-making.
Wall Street analysts forecast NCRA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NCRA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast NCRA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NCRA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
